Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greer

Showing results (751-760 of 765) with videos related to

Pageof 77
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemiasJudith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Circulation|July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeLeslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
The Journal of Clinical Investigation|December 19, 2017
Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhageChe-Feng Chang, Brittany A Goods, Michael H Askenase, et al.
Blood|October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemiaJudith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Blood|December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposideJudith E Karp, Karen Flatten, Eric J Feldman, et al.
Circulation|November 28, 2023
Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement From the American Heart Association and Neurocritical Care SocietyKaren G Hirsch, Benjamin S Abella, Edilberto Amorim, et al.
Stroke|April 30, 2020
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional NeurologyThanh N Nguyen, Mohamad Abdalkader, Tudor G Jovin, et al.
Neurocritical Care|December 1, 2023
Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement from the American Heart Association and Neurocritical Care SocietyKaren G Hirsch, Benjamin S Abella, Edilberto Amorim, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2006
Potent, selective pyrimidinetrione-based inhibitors of MMP-13Lawrence A Reiter, Kevin D Freeman-Cook, Christopher S Jones, et al.
Critical Care Medicine|March 15, 2024
A Modified Delphi Consensus Approach to Define Entrustable Professional Activities for Neurocritical Care Advanced Practice ProvidersDaniel S Harrison, Erika J Sigman, Judy H Ch'ang, et al.
Pageof 77

Showing results (751-760 of 765) with videos related to

Sort By:
Pageof 77
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemiasJudith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Circulation|July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeLeslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
The Journal of Clinical Investigation|December 19, 2017
Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhageChe-Feng Chang, Brittany A Goods, Michael H Askenase, et al.
Blood|October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemiaJudith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Blood|December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposideJudith E Karp, Karen Flatten, Eric J Feldman, et al.
Circulation|November 28, 2023
Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement From the American Heart Association and Neurocritical Care SocietyKaren G Hirsch, Benjamin S Abella, Edilberto Amorim, et al.
Stroke|April 30, 2020
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional NeurologyThanh N Nguyen, Mohamad Abdalkader, Tudor G Jovin, et al.
Neurocritical Care|December 1, 2023
Critical Care Management of Patients After Cardiac Arrest: A Scientific Statement from the American Heart Association and Neurocritical Care SocietyKaren G Hirsch, Benjamin S Abella, Edilberto Amorim, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2006
Potent, selective pyrimidinetrione-based inhibitors of MMP-13Lawrence A Reiter, Kevin D Freeman-Cook, Christopher S Jones, et al.
Critical Care Medicine|March 15, 2024
A Modified Delphi Consensus Approach to Define Entrustable Professional Activities for Neurocritical Care Advanced Practice ProvidersDaniel S Harrison, Erika J Sigman, Judy H Ch'ang, et al.
Pageof 77